SCHOTT Pharma AG & Co. KGaA
- ISIN DE000A3ENQ51
- Country Deutschland
Company profile
Management
Andreas Reisse is CEO of SCHOTT Pharma and has been responsible for this former SCHOTT business unit since 2010. Under his leadership, the company has developed into a leading provider of drug containment solutions and delivery systems, significantly increasing sales and profits in recent years. Previously, the industrial engineer headed the Tubing business unit, which manufactures pharmaceutical glass tubing – the essential starting material for SCHOTT Pharma’s syringes, cartridges, vials and ampoules. During his time at Tubing, Andreas Reisse was also Head of Production in Spain for several years. Overall, he can build on more than 30 years of experience in the pharmaceutical industry. Prior to that, he worked as Head of Procurement for Volkswagen AG.
Follow Andreas Reisse on LinkedIn:
Dr. Almuth Steinkühler joined SCHOTT Pharma at the beginning of 2022. As CFO, she leads the commercial part of the company. In 13 years of experience in previous management roles, she held various finance positions at large German industrial companies. At Thyssenkrupp, she was responsible for Controlling, Accounting and Risk for the Chemical and Process Technologies business unit. In addition, she was an instrumental part in the carve-out for the preparation of a sale of a business unit. She also worked for Continental’s Oil & Marine business in the UK for several years.
Follow Dr. Almuth Steinkühler on LinkedIn:
IR contact
Tobias Erfurth
Head of Investor Relations
If you are a journalist, please contact our Corporate Communications team.
Jasko Terzic, CFA
Senior Manager Investor Relations
If you are a journalist, please contact our Corporate Communications team.
